DAXOR CORP
10-Q/A, 1996-05-31
MISC HEALTH & ALLIED SERVICES, NEC
Previous: CROWN CORK & SEAL CO INC, S-3D, 1996-05-31
Next: DAXOR CORP, 10-K/A, 1996-05-31



                          SECURITIES AND EXCHANGE COMMISSION

                               	WASHINGTON, D.C.  20549

                   	__________________________________________________

                                      	FORM 10-Q

                      	Quarterly Report Under Section 13 or 15(d)
                                        	of the
                                	Securities Act of 1934

                          	FOR QUARTER ENDED MARCH 31, 1996
                           	Commission File Number 0-12248


                                  	DAXOR CORPORATION

                       	(Exact Name as Specified in its Charter)


                      		     New York 				      13-2682108
              	(State or Other Jurisdiction of       (I.R.S. Employer
               Incorporation or Organization)        Identification No.)

                                     	350 Fifth Avenue
                                         	Suite 7120
                                  	New York, New York 10118

                  (Address of Principal Executive Offices & Zip Code)

                   Registrant's Telephone Number:     (212) 244-0555
                      (Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports 
required by Section 13 or 15(d) of the Securities Exchange Act of 1934 
during the preceding 12 months (or for such shorter period that the registrant 
was required to file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.

                                 Yes  (X)               No      

Indicate the number of shares outstanding of each of the issuer's classes of 
common stock, as of the latest practicable date.

       CLASS                         OUTSTANDING AT MARCH 31, 1996 
   COMMON STOCK                                4,722,709
PAR VALUE: $.O1 per share


<PAGE>


PART I.   FINANCIAL INFORMATION



ITEM 1.   FINANCIAL STATEMENTS                              PAGE

		Consolidated Balance Sheets as at
		  March 31, 1996 and December 31, 1995                     2


		Consolidated Statements of Operations for the
            Three Months Ended March 31, 1996 and 1995       3


		Consolidated Statements of Cash Flows for the
		  Three Months ended March 31, 1996 and 1995               4


		Notes to Financial Statements                              5

		              
  Exhibit - 27 Supplementary exhibit as required by the Securities
               And Exchange Commission                  Exhibit 1




<PAGE>






                                    	SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.



                          						DAXOR CORPORATION
								                           (Registrant)




DATE: May 15, 1996                   /s/Joseph Feldschuh         
                             								JOSEPH FELDSCHUH, M.D.
                                        President       
 

DATE: May 15, 1996                   /s/Robert Rosenthal          
                             								ROBERT ROSENTHAL, M.D.
                                 								Vice President 


DATE: May 15, 1996                   /s/Octavia Atanasiu          
                             								OCTAVIA ATANASIU    
                                 								Treasurer


DATE: May 15, 1996                   /s/ Virginia Fitzpatrick      
                             								VIRGINIA FITZPATRICK
                                 								Secretary





<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                         200,654
<SECURITIES>                                33,588,246
<RECEIVABLES>                                  545,735
<ALLOWANCES>                                         0
<INVENTORY>                                    158,000
<CURRENT-ASSETS>                            34,817,101
<PP&E>                                       1,028,850
<DEPRECIATION>                                 628,617
<TOTAL-ASSETS>                              35,256,772
<CURRENT-LIABILITIES>                        4,216,918
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        53,097
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                35,256,772
<SALES>                                        177,676
<TOTAL-REVENUES>                               635,996
<CGS>                                          130,127
<TOTAL-COSTS>                                  734,480
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              19,281
<INCOME-PRETAX>                               (98,484)
<INCOME-TAX>                                    13,311
<INCOME-CONTINUING>                          (111,795)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (111,795)
<EPS-PRIMARY>                                   (0.02)
<EPS-DILUTED>                                   (0.02)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission